FDA inspection
Travere Therapeutics, Inc.: FDA inspection ending Jun 23, 2022
FDA inspection 1174875 · No Action Indicated (NAI) · San Diego, CA
Key facts
| Inspection ID | 1174875 |
|---|---|
| Firm | Travere Therapeutics, Inc. |
| FEI number | 3018103118 |
| Address | 3611 Valley Centre Dr Ste 300 |
| City | San Diego |
| State | CA |
| ZIP | 92130 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Jun 23, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data